GSK plc historic quarter change: Foreign Funds, Added
In funds and trusts that are not on this site's ETF list (sponsor series, commodity pools, money market) (depositary receipts and foreign shares traded over the counter), over 2 quarters from 2025-12-31 to 2026-06-30, GSK plc opened 0 positions, added to 0, reduced 0 and sold out of 0.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1131399), 2 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-13); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2025-12-31.
No position of this class changed this way in the filings compared.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Warberg Asset Management LLC | United States | $0.600B | 192 |
| Matthew Goff Investment Advisor, LLC | United States | $0.600B | 107 |
| Stanley Capital Management, LLC | United States | $0.598B | 40 |
| Beverly Hills Private Wealth, LLC | United States | $0.600B | 499 |
| LONE PEAK GLOBAL INVESTORS LLC | United States | $0.600B | 42 |
| Financial Strategies Group, Inc. | United States | $0.598B | 101 |
| Citizens National Bank Trust Department | United States | $0.601B | 382 |
| Clear Trail Advisors, LLC | United States | $0.601B | 149 |
| Estuary Capital Management LP | United States | $0.598B | 22 |
| ORRSTOWN FINANCIAL SERVICES INC | United States | $0.597B | 123 |